» Articles » PMID: 37351103

Fetal Genome Predicted Birth Weight and Polycystic Ovary Syndrome in Later Life: a Mendelian Randomization Study

Overview
Specialty Endocrinology
Date 2023 Jun 23
PMID 37351103
Authors
Affiliations
Soon will be listed here.
Abstract

Associations between lower birth weight and higher polycystic ovary syndrome (PCOS) risk have been reported in previous observational studies, however, the causal relationship is still unknown. Based on decomposed fetal and maternal genetic effects on birth weight (n  =  406,063), we conducted a two-sample Mendelian randomization (MR) analysis to assess potential causal relationships between fetal genome predicted birth weight and PCOS risk using a large-scale genome-wide association study (GWAS) including 4,138 PCOS cases and 20,129 controls. To further eliminate the maternally transmitted or non-transmitted effects on fetal growth, we performed a secondary MR analysis by utilizing genetic instruments after excluding maternally transmitted or non-transmitted variants, which were identified in another birth weight GWAS (n = 63,365 parent-offspring trios from Icelandic birth register). Linkage disequilibrium score regression (LDSR) analysis was conducted to estimate the genetic correlation. We found little evidence to support a causal effect of fetal genome determined birth weight on the risk of developing PCOS (primary MR analysis, OR: 0.86, 95% CI: 0.52 to 1.43; secondary MR analysis, OR: 0.86, 95% CI: 0.54 to 1.39). In addition, a marginally significant genetic correlation (r = -0.14, se = 0.07) between birth weight and PCOS was revealed LDSR analysis. Our findings indicated that observed associations between birth weight and future PCOS risk are more likely to be attributable to genetic pleiotropy driven by the fetal genome rather than a causal mechanism.

Citing Articles

[Research Progress in the Pathogenesis of Polycystic Ovary Syndrome].

Gao H, Qian B, Ni Y, Sun L, Fu J Sichuan Da Xue Xue Bao Yi Xue Ban. 2024; 55(4):1049-1054.

PMID: 39170002 PMC: 11334293. DOI: 10.12182/20240760208.

References
1.
Power C, Elliott J . Cohort profile: 1958 British birth cohort (National Child Development Study). Int J Epidemiol. 2005; 35(1):34-41. DOI: 10.1093/ije/dyi183. View

2.
Koivuaho E, Laru J, Ojaniemi M, Puukka K, Kettunen J, Tapanainen J . Age at adiposity rebound in childhood is associated with PCOS diagnosis and obesity in adulthood-longitudinal analysis of BMI data from birth to age 46 in cases of PCOS. Int J Obes (Lond). 2019; 43(7):1370-1379. PMC: 6760596. DOI: 10.1038/s41366-019-0318-z. View

3.
Legro R, Roller R, Dodson W, Stetter C, Kunselman A, Dunaif A . Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives. J Clin Endocrinol Metab. 2009; 95(2):789-99. PMC: 2840854. DOI: 10.1210/jc.2009-1849. View

4.
Manikkam M, Crespi E, Doop D, Herkimer C, Lee J, Yu S . Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology. 2003; 145(2):790-8. DOI: 10.1210/en.2003-0478. View

5.
Sathishkumar K, Elkins R, Chinnathambi V, Gao H, Hankins G, Yallampalli C . Prenatal testosterone-induced fetal growth restriction is associated with down-regulation of rat placental amino acid transport. Reprod Biol Endocrinol. 2011; 9:110. PMC: 3162507. DOI: 10.1186/1477-7827-9-110. View